copanlisib
Showing 26 - 30 of 30
HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in Ireland, Spain (Copanlisib,
Terminated
- HER2-positive Breast Cancer
- +3 more
- Copanlisib
- Trastuzumab emtansine
-
Cork, Ireland
- +3 more
Dec 14, 2020
Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in
Completed
- Endometrial Endometrioid Adenocarcinoma
- +5 more
- Copanlisib
- Laboratory Biomarker Analysis
-
New Haven, Connecticut
- +42 more
Jan 25, 2022
Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Positive Trial (Copanlisib, Fulvestrant, Laboratory
Withdrawn
- Estrogen Receptor Positive
- +3 more
- Copanlisib
- +3 more
- (no location specified)
Aug 13, 2018
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022